Latest Bleeding Stories
Janssen Expands EXPLORER Cardiovascular Research Program to Include New, Multi-Trial, Prospective Research Program Aimed at Generating New Evidence in Treating and Preventing Cancer-Associated Blood
DENVER, May 26, 2015 /PRNewswire/ -- Patients with a history of blood clots are commonly prescribed warfarin, an anticoagulant, to decrease the body's ability to form additional clots.
MarketReportsOnline.com adds Global Hemophilia Market Report: 2015 Edition research report of 51 pages on the hemophilia industry to the pharmaceuticals intelligence collection of its research store.
Results Add to Findings from Ongoing Five-Year Post-Marketing Safety Program of XARELTO® Use in Clinical Practice NATIONAL HARBOR, Md., May 15, 2015 /PRNewswire/ -- New data from an ongoing
Patients who are treated with a new clot-removal device after suffering an acute ischemic stroke have significantly reduced disability levels after the event, according to new research led by Dr. Jeffery Saver of the UCLA Stroke Center and the David Geffen School of Medicine.
PLAINSBORO, N.J., April 17, 2015 /PRNewswire/ -- Novo Nordisk is proud to celebrate World Hemophilia Day, which aims to raise awareness of the disease and other inherited bleeding disorders.
DEERFIELD, Ill., April 16, 2015 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported today that partner Baxter International Inc.
Landmark Lightings and Community Activities Honor People Affected by the Disorder WESTON, Mass., April 16, 2015 /PRNewswire/ -- In recognition of World Hemophilia Day,
- Coagulation tests measure a person's blood clotting ability, which can help doctors assess risks of excessive bleeding or developing clots ABBOTT PARK, Ill., April 14, 2015 /PRNewswire/
Surgeons Have New Solution for Controlling Problematic Bleeding Situations During Adult Liver Surgery SOMERVILLE, N.J., April 6, 2015 /PRNewswire/ -- Unexpected and uncontrollable
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.